Press release on the suspension of trading in Mithra Pharmaceutical

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTORITY, PUBLISHED IN APPLICATION OF ARTICLE 7, § 3 OF THE LAW OF 2 AUGUST 2002

Trading in the financial instruments of Mithra Pharmaceutical , BE0974283153, on Euronext Brussels is suspended from 21/06/2017 at 09:00 CET until the publication of a press release.

Source: FSMA

Related Posts